Naturally blonde, brunette…
“Designer ‘therapies’ could one day be helping to restore our hair to its former colour and texture”
Venter Announces $500K Prize for Significant Advances Toward $1,000 Genome
“Just before lunch today at the GSAC conference, Craig Venter stood before the crowd and announced a mouth-watering proposition: a $500,000 Genomic Technology Prize to be awarded by the J. Craig Venter Science Foundation to a person or organization that develops technology ‘to significantly advance’ automated DNA sequencing toward making the $1,000 genome a reality.”
The Odd Couple – CombinatoRx brings matchmaking to drug discovery and development
While almost everyone in the drug industry is looking for ways to speed new drugs to market, CombinatoRx has taken a particularly pragmatic approach: Rather than looking for new drugs, it is searching for novel combinations of existing drugs with synergistic effects.
GlaxoSmithKline Reveals Ingenuity
In a further validation of Big Pharma�s acceptance of systems biology, GlaxoSmithKline has licensed part of the Ingenuity Pathways Knowledge Base to facilitate genome-wide computational analysis of biological systems underlying disease.
The Best in Drugs and Biotech: “S&P’s Herman Saftlas and Frank DiLorenzo share some favorites in these resurgent sectors, including Barr Pharmaceuticals and MedImmune “
What VCs Don’t Tell You: “To secure funding, an entrepreneur needs to appreciate the goals and strategies at work on the other side the table. Here’s a guide “
Building a Better R&D Mousetrap: “By posting their scientific conundrums online, companies like Eli Lilly and Procter & Gamble have discovered a rich new source of brainpower.”
A WTO deal on drugs
India and Brazil are good at making cheap copies of life-saving drugs. Now they are allowed to export them too…
Biotechs big winners in VC rebound
Biotechnology companies are leading a rebound in venture capital investment in the New York metro area, a new survey shows.
Investors put $380 million into 56 companies in the second quarter of this year, for a 63% jump in venture capital investment over the first quarter, according to the MoneyTree Survey by PricewaterhouseCoopers, Thomson Venture Economics and the National Venture Capital Association.
Vatican in favour of GM Food
: “The Vatican has made an endorsement of controversial genetically modified foods by declaring that they hold the answer to world starvation and malnutrition.”